CIMEDO GmbH

🚨 Spoiler Alert! 🚨 Read our upcoming 0100 Conference Mediterranean Speaker Interview with Alexander Vaselek, CEO of CIMEDO GmbH! 🚀 Exciting times for deeptech in Europe and the Mediterranean! With a growing ecosystem fueled by government initiatives and private capital, Europe is positioning itself as a major player in key sectors like AI, biotech, quantum computing, and robotics. While it may still lag behind the U.S. in terms of size and risk appetite, Europe is making significant strides by focusing on sustainability and long-term innovation. 💡 In our conversation, Alexander highlighted deeptech startups' unique challenges, the sectors gaining the most investor attention, and what’s on the horizon for this transformative field. Catch Alexander at the upcoming 0100 Conference Mediterranean in Milan this October, where he’ll be joining the #“DeeptechInvestments” panel alongside industry leaders Maria Cristina Odasso (LIFTT), Stephan Wirries (Ventech), and Dr. Moritz Belling (Earlybird Venture Capital). 🎤 Read the full interview here: https://lnkd.in/dE_YfT5z Register for the 0100 Conference Mediterranean here: https://lnkd.in/d-E5peFd #Deeptech #VC #Innovation #AI #StartupEcosystem #0100Conference

Universal Diagnostics S.A. announces the completion of the funding required for the Signal-C® FDA premarket approval with existing investors, including Quest Diagnostics, and new investors, including Olympus Innovation Ventures. The clinical trial for Signal-C® (https://lnkd.in/dVxuMvxj) is well underway and recruited its first patient in January 2024. The study is on target to reach its recruiting goal of enrolling at least 15,000 patients across 100 investigator sites. Quest Diagnostics operates an oncology center of excellence in Lewisville, Texas, that will serve as the single site for testing for the trial. The parties announced a collaboration in November 2023 under which Quest will have exclusive rights to provide clinical laboratory services in the U.S. assuming FDA approval for the test. UDX is the provider of the results of the assay through its proprietary cloud solution. Once FDA approved, both parties will commercialize the test. “We are thrilled to announce the start of our FDA validation for Signal-C®,” said Juan Martinez-Barea, Chairman of UDX. “After securing the funding required, and having operationally launched our collaboration with Quest, UDX is one step closer to reaching the market with a non-invasive, highly accurate blood test for screening for colorectal cancer. Early detection is crucial, and our technology has the potential to significantly reduce the mortality of this disease.” #liquidbiopsy #FDA #PROMISE #SignalC #colorectalcancer #screening #earlydetection

We're thrilled to announce that Bloom has been acquired by Spring Health. At Bloom our vision has always been to combine self-guided therapy with in-person therapy. And we’re excited have found a partner in Spring Health to continue this vision and help 10M+ people improve their mental health everyday. It’s been a 4-year journey, grateful for the entire Bloom team and amazing talent we worked with over the years. A big thanks to everyone who supported our mission and our journey over the past years. We’re forever grateful to all our user who made Bloom possible. Thank you for 4 beautiful years. With care, Bloom

🤩 SUPER AWESOME BIG NEWS: delphai was acquired by Intapp. 🤝🎉🚀 We'll make our #firmographic #AI engine available to thousands of Intapp's customers in the coming months, and we couldn't be more excited. Both our teams worked super hard on this deal, and it's an honor to make delphai a part of this fantastic company. This comes only 8 months after closing our funding round, and it really is the best next step I could've imagined. We will keep our German office, and our new, expanded AI team will stretch from Singapore, Vilnius, Berlin, and London all the way to New York and Palo Alto (Intapp's HQ). This is amazing news for our partners, customers, users, and #AI for #B2B. A big thank you to everyone who made this happen and who supported our entrepreneurial journey over the years; you're the real deal! Konstanze, Thad, Don, John, Karthik, David H., Mark, Luisa, Berinike, Jens, Jens, Sebastian, Sebastian, Sebastian, Christoph, Christoph, Stephan, Matthias, Brigitte, Alexander, Christian, Christian, Dr. Danyal, Dietmar, Katharina, Robin, Christian, Bill, Will, Matt, Eric, Dr. Karina, Alicia, Jürgen, Lars, Markus, Dorus, Peter, Ralph, and so many more! Thank you 😊 SeekingAlpha's coverage: https://lnkd.in/eC2unqJP